Anteris Technologies Global 

$8.74
28
-$0.23-2.56% Friday 20:00
+$0.01+0.11%Friday 22:08After hours

Statistics

Day High
8.74
Day Low
8.73
52W High
11.06
52W Low
3.3
Volume
24,459
Avg. Volume
-
Mkt Cap
851.79M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.62
-0.48
-0.34
-0.21
Expected EPS
-0.313333
Actual EPS
N/A

Financials

-4,921.28%Profit Margin
Unprofitable
2023
2024
2025
1.91MRevenue
-94.14MNet Income

Analyst Ratings

16.33Average Price Target
The highest estimate is 18.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AVR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Edwards Lifesciences
EW
Mkt Cap51.75B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, directly competing with Anteris's focus on cardiovascular devices.
Medtronic
MDT
Mkt Cap119.49B
Medtronic offers a broad range of medical devices including those for cardiovascular therapy, competing in similar markets as Anteris Technologies.
Boston Scientific
BSX
Mkt Cap73B
Boston Scientific produces medical devices used in interventional medical specialties, including cardiovascular, competing with Anteris's product offerings.
Abbott Laboratories
ABT
Mkt Cap201.83B
Abbott Laboratories has a wide range of medical devices, including for cardiovascular health, making it a competitor in the same space as Anteris.
Stryker
SYK
Mkt Cap126.37B
Stryker Corporation is involved in medical technologies, including surgical equipment and neurovascular products, indirectly competing with Anteris's focus areas.
Zimmer Biomet
ZBH
Mkt Cap19.26B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but its innovations in medical devices place it as a competitor in the broader medical device market.
Intuitive Surgical
ISRG
Mkt Cap133.83B
Intuitive Surgical, known for its robotic surgical systems, competes in the innovative medical device space, indirectly affecting companies like Anteris.
Baxter International
BAX
Mkt Cap13.62B
Baxter International develops, manufactures, and markets healthcare products, including hospital and renal care products, competing in the healthcare solutions sector.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson's medical device segment offers a broad range of products that compete across various sectors, including cardiovascular.
Integra Lifesciences
IART
Mkt Cap1.3B
Integra LifeSciences, a provider of regenerative technologies, surgical instrumentation, and neurosurgical products, competes in the medical technology and device market.

About

Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
Show more...
CEO
Wayne Geoffrey Paterson
Employees
174
Country
United States
ISIN
US03675P1021

Listings

0 Comments

Share your thoughts

FAQ

What is Anteris Technologies Global stock price today?
The current price of AVR is $8.74 USD — it has decreased by -2.56% in the past 24 hours. Watch Anteris Technologies Global stock price performance more closely on the chart.
What is Anteris Technologies Global stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Anteris Technologies Global stocks are traded under the ticker AVR.
Is Anteris Technologies Global stock price growing?
AVR stock has fallen by -2.67% compared to the previous week, the month change is a +10.63% rise, over the last year Anteris Technologies Global has showed a +117.41% increase.
What is Anteris Technologies Global market cap?
Today Anteris Technologies Global has the market capitalization of 851.79M
When is the next Anteris Technologies Global earnings date?
Anteris Technologies Global is going to release the next earnings report on November 18, 2026.
What were Anteris Technologies Global earnings last quarter?
AVR earnings for the last quarter are -0.3 USD per share, whereas the estimation was -0.21 USD resulting in a -44.72% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Anteris Technologies Global revenue for the last year?
Anteris Technologies Global revenue for the last year amounts to 1.91M USD.
What is Anteris Technologies Global net income for the last year?
AVR net income for the last year is -94.14M USD.
How many employees does Anteris Technologies Global have?
As of August 29, 2026, the company has 174 employees.
In which sector is Anteris Technologies Global located?
Anteris Technologies Global operates in the Health & Wellness sector.
When did Anteris Technologies Global complete a stock split?
The last stock split for Anteris Technologies Global was on February 21, 2006 with a ratio of 1:50.
Where is Anteris Technologies Global headquartered?
Anteris Technologies Global is headquartered in EAGAN, United States.